Literature DB >> 9657112

Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins.

D Moradpour1, P Kary, C M Rice, H E Blum.   

Abstract

Investigation of the hepatitis C virus (HCV) life cycle and the evaluation of novel antiviral strategies are limited by the lack of an efficient cell culture system. Therefore, continuous human cell lines inducibly expressing the entire HCV open reading frame were generated with use of a tetracycline-regulated gene expression system. HCV transgenes were found to be chromosomally integrated in a head-to-tail configuration. Northern blot analyses revealed a tightly regulated unspliced transcript of approximately 9 kilobases (kb). HCV structural and nonstructural proteins were faithfully processed, indicating that the cellular and viral proteolytic machineries and posttranslational modification pathways are fully functional in these cell lines. Steady state expression levels could be regulated over a broad range by the concentration of tetracycline present in the culture medium. Kinetic analyses revealed a half-life of less than 1 hour for the HCV RNA whereas a half-life of approximately 9.5, 12, 11, and 10 hours was found for core, NS3, NS4A, and NS5A proteins, respectively. Viral proteins were found to colocalize in the cytoplasm in a pattern characteristic of the endoplasmic reticulum. High-level expression of HCV proteins in the fully induced state was toxic to the cells. These cell lines provide a unique in vitro system to analyze structural and functional properties of HCV proteins, their interactions with cellular proteins and pathways, and the requirements for HCV morphogenesis. In addition, they should prove useful for the evaluation of novel antiviral strategies against hepatitis C in a well-defined and reproducible cellular context.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657112     DOI: 10.1002/hep.510280125

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

1.  Subcellular localization and topology of the p7 polypeptide of hepatitis C virus.

Authors:  Séverine Carrère-Kremer; Claire Montpellier-Pala; Laurence Cocquerel; Czeslaw Wychowski; François Penin; Jean Dubuisson
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  Viral determinants of resistance to treatment in patients with hepatitis C.

Authors:  Anette Wohnsland; Wolf Peter Hofmann; Christoph Sarrazin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1.

Authors:  Francois H T Duong; Verena Christen; Jan Martin Berke; Sabina Hernandez Penna; Darius Moradpour; Markus H Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Functional and Physical Interaction between the Arf Activator GBF1 and Hepatitis C Virus NS3 Protein.

Authors:  Nadjet Lebsir; Lucie Goueslain; Rayan Farhat; Nathalie Callens; Jean Dubuisson; Catherine L Jackson; Yves Rouillé
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.

Authors:  Heather J Ezelle; Dubravka Markovic; Glen N Barber
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame.

Authors:  Weiliang Tang; Catherine A Lázaro; Jean S Campbell; W Tony Parks; Michael G Katze; Nelson Fausto
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

7.  Folding of hepatitis C virus E1 glycoprotein in a cell-free system.

Authors:  M Merola; M Brazzoli; F Cocchiarella; J M Heile; A Helenius; A J Weiner; M Houghton; S Abrignani
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Identification of GBF1 as a cellular factor required for hepatitis C virus RNA replication.

Authors:  Lucie Goueslain; Khaled Alsaleh; Pauline Horellou; Philippe Roingeard; Véronique Descamps; Gilles Duverlie; Yann Ciczora; Czeslaw Wychowski; Jean Dubuisson; Yves Rouillé
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells.

Authors:  Keith D Tardif; Aleem Siddiqui
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Identification of a novel determinant for membrane association in hepatitis C virus nonstructural protein 4B.

Authors:  Jérôme Gouttenoire; Valérie Castet; Roland Montserret; Naveen Arora; Vincent Raussens; Jean-Marie Ruysschaert; Eric Diesis; Hubert E Blum; François Penin; Darius Moradpour
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.